Table 7.

Treatment effect of dialysate to serum sodium alignment on volume-related and hemodynamic parameters in those patients part to this quality initiative (intention-to-treat cohort; N = 163) and the propensity score matched control cohort (N = 163)

Parameter	Study Regimen	Baseline	Follow-up	Difference (95% CI)	Treatment effect (95% CI)
Pre HD SBP [mmHg]	aligned	145.17+/−20.05	143.95+/−20.57	−1.22 (−5.65 to 3.2)	1.19 (−1.07 to 3.44)
	unaligned	145.12+/−19.33	142.7+/−19.7	−2.41 (−6.66 to 1.84)
Post HD SBP [mmHg]	aligned	135.1+/−17.72	134.36+/−17.68	−0.74 (−4.6 to 3.12)	1.21 (−0.86 to 3.28)
	unaligned	137.08+/−18.12	135.1+/−18.3	−1.95 (−5.92 to 2.02)
Pre HD DBP [mmHg]	aligned	74.12+/−12.25	73.59+/−12.16	−0.53 (−3.19 to 2.13)	0.3 (−0.91 to 1.51)
	unaligned	75.62+/−11.47	74.8+/−11.1	−0.83 (−3.3 to 1.63)
Post HD DBP [mmHg]	aligned	69+/−10.39	68.83+/−10.49	−0.17 (−2.45 to 2.1)	0.43 (−0.67 to 1.53)
	unaligned	71.39+/−10.21	70.8+/−10.1	−0.6 (−2.82 to 1.61)
Pre HD PP [mmHg]	aligned	71.06+/−14.92	70.36+/−15.52	−0.69 (−4.01 to 2.62)	0.89 (−0.59 to 2.36)
	unaligned	69.5+/−14.11	67.9+/−14.9	−1.58 (−4.74 to 1.58)
Post HD PP [mmHg]	aligned	66.1+/−12.89	65.53+/−13.09	−0.57 (−3.4 to 2.27)	0.78 (−0.59 to 2.15)
	unaligned	65.69+/−13.27	64.3+/−13.6	−1.35 (−4.27 to 1.58)
Pre HD MAP [mmHg]	aligned	97.8+/−13.58	97.04+/−13.64	−0.76 (−3.73 to 2.21)	0.6 (−0.88 to 2.08)
	unaligned	98.79+/−12.96	97.4+/−12.7	−1.36 (−4.16 to 1.44)
Post HD MAP [mmHg]	aligned	91.03+/−11.82	90.67+/−11.81	−0.36 (−2.94 to 2.21)	0.69 (−0.66 to 2.04)
	unaligned	93.29+/−11.83	92.2+/−11.8	−1.05 (−3.63 to 1.52)
Intra HD SBP change [mmHg]	aligned	−10.07+/−13.7	−9.59+/−13.34	0.48 (−2.46 to 3.43)	0.02 (−2.12 to 2.16)
	unaligned	−8.04+/−13.94	−7.6+/−13.5	0.46 (−2.53 to 3.45)
Intra HD DBP change [mmHg]	aligned	−5.12+/−6.81	−4.76+/−6.47	0.36 (−1.09 to 1.8)	0.13 (−0.9 to 1.15)
	unaligned	−4.24+/−6.59	−4+/−6.5	0.23 (−1.2 to 1.66)